🇺🇸 ASTRAZENECA PLCAZN
Get ASTRAZENECA PLC filings on Telegram the moment they are published.
Follow ASTRAZENECA PLC on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 6-K — Foreign issuer report
Overview: The European Union approved Enhertu for adjuvant treatment of HER2-positive early breast cancer, triggering a $75 million milestone payment to Daiichi Sankyo.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest